Meeting
2019 Genitourinary Cancers Symposium
Analysis of EGFR mutant upper tract and bladder urothelial carcinoma (UC) reveals distinct mutational landscape.
Authors
Russell Madison
Foundation Medicine, Inc., Cambridge, MA
Russell Madison , Sumati Gupta , Jeffrey S. Ross , Alexa Betzig Schrock , Luke Juckett , Vincent A. Miller , Brian Michael Alexander , Sumanta K. Pal , John Heymach , Andrea Necchi , Jay L Koyner , Siraj Mahamed Ali , Jon Chung , Venkataprasanth P. Reddy
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 416)
DOI
10.1200/JCO.2019.37.7_suppl.416
Abstract #
416
Poster Bd #
H7
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Analysis of EGFR mutant urothelial carcinoma (UC) reveals distinct mutational landscape.
First Author: Russell Madison
Poster
2024 ASCO Genitourinary Cancers Symposium
Genomic profiling of bladder cancer in waterpipe and cigarette smokers: Implications for carcinogenicity and genetic landscape.
First Author: Ali Shamseddine
Poster
2023 ASCO Genitourinary Cancers Symposium
Landscape of genomic alterations (GA) in urothelial bladder carcinoma (UBC) in patients of East Asian and South Asian ancestry.
First Author: Taylor Peak
Poster
2022 ASCO Genitourinary Cancers Symposium
Expanding the use of targeted therapy for urothelial bladder cancer (UBC): Non-FGFR3 receptor tyrosine kinase (RTK) gene rearrangements (ReAr) and fusions (fus).
First Author: Andrea Necchi